GlassScriptPhysician profile
Brittany M Ball
NPI 1902449044
$1,791.22
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,545 · 2022: $247.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $290.96 | 2021-2022 | |
| Abbvie INC. | $216.48 | 2021-2022 | |
| Mannkind Corporation | $211.07 | 2021 | |
| Medtronic, INC. | $141.84 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $124.49 | 2021 | |
| Dexcom, INC. | $117.33 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.55 | 2021 | |
| Merck Sharp & Dohme LLC | $75.50 | 2021 | |
| Amgen INC. | $73.48 | 2021-2022 | |
| Corcept Therapeutics | $62.64 | 2021 | |
| Pfizer INC. | $57.45 | 2021 | |
| Xeris Pharmaceuticals, INC. | $55.72 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $44.75 | 2021 | |
| Tandem Diabetes Care, INC. | $38.79 | 2021 | |
| Ibsa Pharma INC. | $31.63 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eusa Pharma (US) LLC | $24.65 | 2022 | |
| Recordati_rare_diseases_inc. | $24.65 | 2022 | |
| Insulet Corporation | $19.38 | 2021 | |
| Antares Pharma, INC. | $19.14 | 2021 | |
| Amneal Pharmaceuticals LLC | $17.41 | 2021 | |
| Clarus Therapeutics INC. | $14.87 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.44 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.